AI analysis of one-year CT changes predicts disease progression and survival in fibrotic interstitial lung disease.
Key Details
- 1Researchers at National Jewish Health used an AI-based tool to detect subtle increases in lung fibrosis on serial CT scans.
- 2A 5% or more increase in fibrosis score over one year doubled the risk of death or lung transplant for patients.
- 3AI-derived fibrosis changes predicted steeper lung function decline, especially in patients with less severe baseline disease.
- 4The deep learning method, data-driven textural analysis (DTA), provided precise, objective fibrosis quantification.
- 5Results were validated with data from the Pulmonary Fibrosis Foundation Patient Registry, demonstrating generalizability.
- 6Quantitative CT analysis could be used for trial endpoints and real-world risk stratification.
Why It Matters
This study demonstrates the clinical potential of deep learning-based CT quantification for early risk identification and outcome prediction in fibrotic lung disease. It supports wider use of imaging AI as an objective, reproducible tool for prognosis and treatment decision-making in complex pulmonary disorders.
Source
EurekAlert
Related News
•EurekAlert
New VIS-Fb Nanobody Probes Transform High-Precision Cellular Imaging
Salk and Einstein researchers have developed visible-spectrum antigen-stabilizable fluorescent nanobodies (VIS-Fbs) for sharper, multi-color live-cell imaging with minimal background noise.
•EurekAlert
NIH-Backed AI Model Predicts Cancer Survival Using Single-Cell Data
Researchers have developed scSurvival, a machine learning tool that uses single-cell tumor data to accurately predict cancer patient survival and identify high-risk cell populations.
•EurekAlert
Deep Learning Pathomics Platform Improves Immunotherapy Prediction in Lung Cancer
A deep learning pathomics platform accurately predicts immunotherapy response in metastatic NSCLC using routine pathology slides.